| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/05/2023 | 138.1% | Maxim Group | → $5 | Initiates Coverage On | → Buy |
| 10/04/2023 | 423.81% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 09/28/2023 | 423.81% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 08/15/2023 | 423.81% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 07/17/2023 | 423.81% | HC Wainwright & Co. | $9 → $11 | Maintains | Buy |
| 05/30/2023 | 328.57% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
| 05/02/2023 | 233.33% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 04/04/2023 | 233.33% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/13/2023 | 233.33% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/08/2023 | 233.33% | HC Wainwright & Co. | $8 → $7 | Maintains | Buy |
| 08/30/2022 | 280.95% | HC Wainwright & Co. | $3 → $8 | Maintains | Buy |
| 01/18/2022 | 42.86% | HC Wainwright & Co. | $5 → $3 | Maintains | Buy |
| 09/07/2021 | 138.1% | HC Wainwright & Co. | $5.5 → $5 | Maintains | Buy |
| 02/08/2021 | 161.9% | HC Wainwright & Co. | $9 → $5.5 | Maintains | Buy |
| 04/07/2020 | 328.57% | HC Wainwright & Co. | $11 → $9 | Maintains | Buy |
| 11/12/2019 | 185.71% | Piper Sandler | $10 → $6 | Maintains | Overweight |
| 06/25/2019 | 423.81% | Cantor Fitzgerald | → $11 | Initiates Coverage On | → Overweight |
| 06/24/2019 | 376.19% | Piper Sandler | → $10 | Initiates Coverage On | → Overweight |
| 10/19/2018 | 423.81% | IFS Securities | → $11 | Downgrades | Strong Buy → Outperform |
What is the target price for Rockwell Medical (RMTI)?
The latest price target for Rockwell Medical (NASDAQ: RMTI) was reported by Maxim Group on October 5, 2023. The analyst firm set a price target for $5.00 expecting RMTI to rise to within 12 months (a possible 138.10% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Rockwell Medical (RMTI)?
The latest analyst rating for Rockwell Medical (NASDAQ: RMTI) was provided by Maxim Group, and Rockwell Medical initiated their buy rating.
When is the next analyst rating going to be posted or updated for Rockwell Medical (RMTI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rockwell Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rockwell Medical was filed on October 5, 2023 so you should expect the next rating to be made available sometime around October 5, 2024.
Is the Analyst Rating Rockwell Medical (RMTI) correct?
While ratings are subjective and will change, the latest Rockwell Medical (RMTI) rating was a initiated with a price target of $0.00 to $5.00. The current price Rockwell Medical (RMTI) is trading at is $2.10, which is within the analyst's predicted range.
